Positions

Principal Investigator On

Investigator On

  • Cervical Cancer Derived Xenografts (PDX) and Organoid Raft Cultures to Evaluate Pathway Specific Therapeutic Agents.  awarded by National Cancer Institute/NIH/DHHS 2019 - 2020
  • In Vitro Assessment for Antimicrobial Activity - B07 HHSN27200002 Comprehensive Virus Panel 2  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2011 - 2019
  • In Vitro Assessment for Antimicrobial Activity - B09 HHSN27200003 Comprehensive Panel for Viruses  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2011 - 2019
  • In Vitro Assessment for Antimicrobial Activity - B12 HHSN27200005 Comprehensive Panel for Viruses  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2011 - 2019
  • In Vitro Assessments for Antimicrobial Activity  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2011 - 2019
  • In Vitro Assessments for Antimicrobial Activity - B14 - HHSN27200004 Papillomavirus Assay  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2011 - 2019
  • In Vitro Assessments for Antimicrobial Activity - B16 - HHSN27200007 Comprehensive Panel for Viruses  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2011 - 2019
  • Mechanisms of Human Papillomavirus DNA Replication  awarded by National Cancer Institute/NIH/DHHS 2011 - 2017
  • Zambian Cervical Cancer Research Capacity Initiative  awarded by University of North Carolina at Chapel Hill 2012 - 2015
  • Private Grant  awarded by TAMIR BIOTECHNOLOGY 2013 - 2014

    • Education And Training

  • Doctor of Philosophy in Biochemistry, Stanford University 1972

    • Full Name

  • Thomas Broker